Posted on 12/10/2023 7:58:36 PM PST by SeekAndFind
Perhaps, but remember we are talking about drugs partially funded by our tax dollars. We are stake holders and at a minimum should be getting royalties.
No more tax payer handouts for international corporations and big pharma. They invest their profits in supporting progressive polotitions and causes.
The Biden administration has proposed a new rule.
My the castle is busy of late.
Yes, “we’re here to help”
Being in the industry, a few things that will happen: 1 - new drug development ceases. The investment into developing specialty drugs is staggering in time, effort and dollars. 2 - pull out from government contracts including 340B, DOD/Tricare, Medicare, etc. 3 - layoffs resulting from 1 and 2. 4 - long court cases as this gets flushed out with oddly enough no short term relief at all for patients as you can’t just switch from one manufacturing site to another. So many supply chain implications, active pharmaceutical purchasing agreements, facility and equipment qualification, distribution agreements, etc. if they would just STOP and reform PBMs it would have an immediate impact. Today they hold Pharma hostage by threatening to not recommend drugs for formulary placement unless they are paid rebates. Follow Drug Channels and Adam Fein to chase the money. A Pharma company sells drug X for $200 and by the time it gets through the supply chain and PBMs that same drug is now $6000. There is more wrong than just Pharma list pricing.
I am not sure they are exactly taxpayer funded, directly. I think there is a cozy deal in place but its not the same as the US saying Pfizer, make an aids drug.
I need to look that up.
What a ghastly, horrible idea for the government to have total power over a medication. Awful potential for politiicized domestic wounding or genocide. Just no.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.